Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Basal-IQ Technology

K-Number: K193483 · 2020-02-28

Decision Date2020-02-28
Product CodeQJS
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Basal-IQ Technology is a medical device manufactured by Tandem Diabetes Care, Inc.. It received FDA 510(k) clearance on 2020-02-28 under approval number K193483. The device is classified under product code QJS. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Basal-IQ Technology?

Basal-IQ Technology is a medical device that received FDA 510(k) clearance on 2020-02-28. It is manufactured by Tandem Diabetes Care, Inc.. The 510(k) number is K193483.

When was Basal-IQ Technology approved by the FDA?

Basal-IQ Technology received FDA 510(k) clearance on 2020-02-28, under approval number K193483.

What company makes Basal-IQ Technology?

Basal-IQ Technology is manufactured by Tandem Diabetes Care, Inc..

What is the FDA product code for Basal-IQ Technology?

The FDA product code for Basal-IQ Technology is QJS.

Related Clinical Trials

Other Devices by Tandem Diabetes Care, Inc.

View all 22 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.